ETCEMBLY LTD
Company number 12059749 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£3,771,676
Balance sheet as at 2022-06-30
Overview
- Company type
- Private Limited Company
- Incorporated
- 2019-06-19
- Employees
- -13 (2022 accounts · was -4 in 2021)
- Registered office
- Etcembly Ltd Quad One, Becquerel Avenue, Harwell Campus, Oxfordshire, United Kingdom, OX11 0RA
- Postcode
- OX11 0RA
- Capital
- 1 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-06-30
- Next due by
- 2027-03-31
- Financial year end
- 30 June
Confirmation statement
- Last statement dated
- 2026-02-26
- Next due by
- 2027-03-12
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 5 current · 1 resigned
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Data protection registration
Registered with the ICO as a data protection fee payer — ZB362688 (Tier 1), registered since 2022.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- etcembly.com
From Code to Cure: Etcembly combines cutting-edge artificial intelligence and bioengineering to accelerate therapeutic innovation and design next-generation immunotherapies. Learn how we’re shaping the future of precision medicine.
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 42 BUXTON AVENUE, CAVERSHAM, READING, RG4 7BU, ENGLAND | 2019-08-05 |
Among its peers
Top 25%
by shareholders' funds, of 179 similar companies in OX
Trading since 2019.
Competitors Oxford
This company ranks 29 among research and experimental development on biotechnology in Oxford.
The class of 2019
39%
of the 500 companies in this sector incorporated in 2019 are still active today; 57% have since been dissolved.
A fact about the year, not a forecast for this company.